Ohio Governor Race Tests Voters on Covid, Health Costs, Science Trust
The contest between Amy Acton and Vivek Ramaswamy may be the clearest gauge of Midwestern attitudes toward pandemic policy and public health expertise.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
MRI study: 'Reporter game' calms sensory-brain activity in autistic youth
A brain-imaging study suggests a simple reporting game can help autistic youth regulate overactive sensory responses.
VA and DoD Guideline Names Preferred Tobacco Cessation Treatments
A new joint clinical guideline identifies varenicline and combination nicotine replacement therapy as first-line options for tobacco cessation in veterans and service members.
Why Heart-Diabetes Patients Face More Hospital Stays
New research highlights how coronary heart disease and type 2 diabetes together amplify post-heart-attack hospitalization risk.
Genicular Artery Embolization Shows Promise as Knee Replacement Alternative
A minimally invasive procedure that blocks inflammation-related blood vessels may offer a new middle ground for osteoarthritis patients.
Engineered immune cells target artery plaque in UCLA study
A new UCLA-developed immune cell therapy is designed to attack the fatty artery plaques behind most heart attacks and strokes.
Epic Mortality Model and Omada Expansion Highlight Health Tech Trends
A STAT Health Tech newsletter reports on Epic's mortality prediction algorithm for geriatrics and Omada's product expansion plans.
Study links enlarged breast tissue to migraine, neck pain, sleep apnea
New research from Wake Forest University School of Medicine suggests women with macromastia face higher odds of several chronic conditions.
AI Health Workers Need Probation Periods, Not Just Pilots
Healthcare lacks a shared playbook for onboarding AI agents expected to do end-to-end jobs, and a probation period could fill that gap.
Dozens Sue GLP-1 Makers Over Eye Risk Warning
Lawsuits allege GLP-1 receptor agonist manufacturers failed to warn patients about the risk of non-arteritic anterior ischemic optic neuropathy.
Study: Over a third of positive mpox tests may be false
A new analysis suggests that many mpox diagnoses during the 2024 emergency may have been incorrect, complicating response efforts.
How fear and rejection underpin OCD, not just neat-freak stereotypes
A new article challenges common OCD stereotypes, suggesting the disorder is driven by fear of rejection and self-doubt rather than a preference for cleanliness.
4D fMRI CrossFormer boosts transparency and efficiency in AI brain screening
A new vision transformer architecture from Sungkyunkwan University analyzes 4D fMRI data with greater computational efficiency and interpretability for brain-disorder screening.
Pediatric Acute Kidney Injury Hospitalizations Rose Tenfold Since 1997
A large retrospective study found a tenfold increase in pediatric acute kidney injury hospitalizations over 25 years, with improved overall mortality but no change for children needing dialysis.
Lexeo Acquires Mantle for $8.3M, Expanding Friedreich Ataxia Pipeline
Lexeo Therapeutics is acquiring Mantle Therapeutics for $8.3 million upfront to broaden its Friedreich ataxia portfolio and secure three collaborations for its lead asset.
Travere CEO Eric Dube Steps Down; Amicus Veteran Bradley Campbell to Lead
Eric Dube, who transformed Travere Therapeutics and launched its kidney disease drug Filspari, is leaving for health and family reasons, with Bradley Campbell taking over as CEO.
Otsuka, Ionis ALS drug meets phase 3 goal, heads to FDA talks
A phase 3 trial of the partners' amyotrophic lateral sclerosis candidate succeeded on its primary endpoint, opening the door to expedited regulatory discussions.
Survey: One in Three UK Women Say Migraine Pain Dismissed Due to Gender
A new Organon-commissioned survey suggests gender bias may play a role in how UK women's migraine pain is perceived.